LASA

Lasa Supergenerics Share Price

 
Stock Hit Upper Circuit

 

Lasa Supergenerics live price: ₹7.7. It opened at ₹8 vs previous close ₹8; intraday high/low: ₹8/₹8. The 50 & 200 DMA stand at ₹7.75/₹10.82.

Lasa Supergenerics Performance

  • Today's Low
  • ₹8
  • Today's High
  • ₹8
  • 52 Week Low
  • ₹6
  • 52 Week High
  • ₹19
  • Open Price₹8
  • Previous Close₹8
  • Volume62,374
  • 50 DMA₹7.75
  • 100 DMA₹8.72
  • 200 DMA₹10.82

Investment Returns

  • Over 1 Month -0.52%
  • Over 3 Month -29.49%
  • Over 6 Month -31.07%
  • Over 1 Year -56.89%

Smart Investing Starts Here Start SIP with Lasa Supergenerics for Steady Growth!

Invest Now

Lasa Supergenerics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -0.9
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 39
  • P/B Ratio
  • 0.7
  • Average True Range
  • 0.48
  • EPS
  • 0.05
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.46
  • RSI
  • 55.87
  • MFI
  • 25.33

Lasa Supergenerics Financials

Lasa Supergenerics Technicals

EMA & SMA

Current Price
₹7.70
+ 0.14 (1.85%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹7.00
  • 50 Day
  • ₹7.75
  • 100 Day
  • ₹8.72
  • 200 Day
  • ₹10.82

Resistance and Support

7.42 Pivot Speed
  • R3 8.15
  • R2 7.86
  • R1 7.71
  • S1 7.27
  • S2 6.98
  • S3 6.83

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Lasa Supergenerics has an operating revenue of Rs. 64.41 Cr. on a trailing 12-month basis. An annual revenue growth of 41% is outstanding, Pre-tax margin of -14% needs improvement, ROE of -17% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Lasa Supergenerics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-05-28 Audited Results (Revised) per share(2.5%)Final Dividend
2025-02-13 Quarterly Results

Lasa Supergenerics F&O

Lasa Supergenerics Shareholding Pattern

53.65%
0%
42.04%
4.31%

Lasa Supergenerics FAQs

Lasa Supergenerics share price is ₹7 As on 10 April, 2026 | 14:19

The Market Cap of Lasa Supergenerics is ₹38.6 Cr As on 10 April, 2026 | 14:19

The P/E ratio of Lasa Supergenerics is -0.9 As on 10 April, 2026 | 14:19

The PB ratio of Lasa Supergenerics is 0.7 As on 10 April, 2026 | 14:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23